METZGER MICHAEL A (President and COO) sold 4.2% of their position (13.29K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $206.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2025ACC: 0000950170-25-019000
Officer· President and COO
Since Feb 2019
-13.29K
Net shares
Net seller
$206.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
13.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−13.29K
Price / share
$15.50
Trade value
$206.02K
% of position
4.2%
2/10/2025
313.41K→300.12K
Total
Net shares
−13.29K
Net value
-$206.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2025 | S · Sale | −13.29K | $15.50 | $206.02K | 4.2% | 313.41K | 300.12K |
| Total | −13.29K | -$206.02K | ||||||
Derivative Transactions0
No derivative transactions reported